Home  >  Products  >  PARK7 (Parkinson disease (autosomal recessive, early onset) 7) Blocking Peptide (the C terminal of protein) (100ug)
PARK7 (Parkinson disease (autosomal recessive, early onset) 7) Blocking Peptide (the C terminal of protein) (100ug)

PARK7 (Parkinson disease (autosomal recessive, early onset) 7) Blocking Peptide (the C terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PARK7 antibody (Catalogue #: ARP51267_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP51267
Size: 100 ug
Weight: 20kDa
Gene: 11315
Format: Lyophilized powder
Target: PARK7 belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7.The product of this gene belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress and cell death. Defects in this gene are the cause of autosomal recessive early-onset Parkinson disease 7. Two transcript variants encoding the same protein have been identified for this gene.
Alternative names: DJ-1; DJ1; FLJ27376
See Full Product Listings >